• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1422120-J
Device Problems Deformation Due to Compressive Stress (2889); Unintended Movement (3026)
Event Date 04/24/2023
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the alto abdominal aortic aneurysm stent system.Approximately one (1) month post initial procedure, the patient presented with a proximal right iliac stent compression (greater than 50 percent), bilateral type ib endoleaks and outflow to the lumbar arteries (classified as a non-device-related type ii endoleak).The patient will continue to be monitored.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported ovation ix, right iliac stent compression, non-device-related type ii endoleak (of the lumbar arteries, and type ib endoleak (of the right and left distal limbs) are confirmed.This is consistent with the reported adverse event/incident.No procedure-related harms were identified.Device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was reported as discharged home on postoperative day three.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: g3 awareness date.H6 investigation finding codes; remove 3233.H6 investigation conclusion codes; remove 11.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the alto abdominal aortic aneurysm stent system.Approximately one (1) month post initial procedure, the patient presented with a proximal right iliac stent compression (greater than 50 percent), bilateral type ib endoleaks and outflow to the lumbar arteries (classified as a non-device-related type ii endoleak).The patient will continue to be monitored.Additional information: both limbs are pulled up proximally beyond the margins of the very short common iliacs resulting in the bilateral type 1b endoleaks.The physician elected to re-intervene and extended bilaterally with ovation ix iliac limbs on (b)(6) 2023 to resolve this event.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported ovation ix, right iliac stent compression, non-device-related type ii endoleak (of the lumbar arteries, type ib endoleak (of the right and left distal limbs) and additional endovascular procedure are confirmed.This is consistent with the reported adverse event/incident.Additionally, both limbs are pulled up proximally beyond the margins of the very short common iliacs resulting in the bilateral type 1b endoleaks.The physician elected to re-intervene and extended bilaterally with ovation ix iliac limbs on 09/13/2023 to resolve this event.No procedure-related harms were identified.Device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was reported as discharged home on postoperative day three.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Type of Device
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key16996793
MDR Text Key315910066
Report Number3008011247-2023-00067
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00850007370336
UDI-Public(01)00850007370336(17)250812(10)FS081122-65
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Study,Health Professional
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 05/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTV-IL1422120-J
Device Catalogue NumberTV-IL1422120-J
Device Lot NumberFS081122-65
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALTO MAIN BODY, LN FS010423-01.; OVATION IX ILIAC LIMB, LN FS083022-53.; OVATION PRIME FILL POLYMER, LN FF070722-01.
Patient Outcome(s) Other; Required Intervention;
Patient Age74 YR
-
-